3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Disease
1
Carcinoma, Renal Cell
1
Interventions
Prednisone
3
pembrolizumab
2
Melphalan
2
Cytarabine
2
venetoclax
1
ofatumumab
1
obinutuzumab
1
ioflupane
1
imetelstat
1
ibrutinib
1
gossypol acetic acid
1
gilteritinib
1
fluorocholine
1
fluciclovine F-18
1
deltacortene
1
daratumumab
1
aflibercept
1
abiraterone
1
Temozolomide
1
Self-Management
1
Quality of Life
1
Professional Autonomy
1
Paclitaxel
1
Oncolytic Virotherapy
1
Octreotide
1
Mitoxantrone
1
Methylene Blue
1
Lenalidomide
1
Gemtuzumab
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Disease
×
ioflupane
×
Clear all
NCT03185182
2019-06-21
RCCSCAN
Region Skane
Phase 2
Terminated
5 enrolled
5 charts